NCAB Puts 20% Cap On P01 Budget Raises To Stem Requests Exceeding NCI’s.
Bishop Completes Term As NCAB Chairman; Terms Of Five Extended Awaiting W.H. Action.
UNC Lineberger Appoints Two, Zaret Wins Chair At Fox Chase.
NCI, SAIC To Support Contracts For Molecular Target Labs.
NCAB: An Extraordinary Opportunity For Budgetary Coordination.
Aetna No Longer To Cover HDC/BMT For Breast Cancer Outside Of Clinical Trials.
BioMedicines Begins Kidney Cancer Study; EntreMed Moves Forward.
Aventis, MediGene In Pact For Development Of Vaccine.
Firm To Study Imaging System As Adjunct To Mammogram.
Techniclone Wins Patent For Tumor Necrosis Therapy.
Trending Stories
- Class action complaint alleging GRAIL insider fraud resubmitted after dismissal
- Cancer centers adapt to life without site visits as NIH changes CCSG review
- How GLP-1RA drugs are reshaping patient physiology and the future of oncology
- Jonathan Licht named president, chief scientific officer at Van Andel Institute
- Friends publishes three white papers ahead of annual meeting
Topics: Clinical trials on rare cancers, combination drug trials, multi-regional studies - Early endpoints are a balance of risk and benefit









